文献速递血栓与止血

全外显子组测序识别与静脉血栓栓塞性疾病相关的STAB2罕见变异

Whole-exome sequencing identifies rare variants in STAB2 associated with venous thromboembolic disease.
PubMed 文献 · Blood · 2020-01-01

研究对393例无诱因静脉血栓栓塞症(VTE)患者和6114例对照进行全外显子组测序,发现PROS1、STAB2、PROC和SERPINC1四个基因携带过多罕见损伤性变异。STAB2中7.8%的VTE病例和2.4%的对照携带合格罕见变异,且STAB2的VTE相关变异在细胞培养中表面表达降低。独立队列中,携带罕见STAB2变异者血管性血友病因子水平高于对照,前肽水平相当。

要点

  • 全外显子组分析识别出PROS1、STAB2、PROC和SERPINC1四个VTE风险基因。
  • STAB2罕见变异见于7.8%的VTE病例和2.4%的对照。
  • STAB2的VTE相关变异在细胞培养中表面表达降低。

核心结论

  • 本研究证明基于基因的合并分析可用于识别与复杂血栓性疾病存在功能关联的、携带过多罕见变异的位点。

研究设计与样本

  • 对393例无诱因VTE患者和6114例对照进行全外显子组研究。

主要发现

  • 发现PROS1、STAB2、PROC和SERPINC1四个基因在VTE患者中携带过多罕见损伤性变异。
  • STAB2中,7.8%的VTE病例和2.4%的对照携带合格罕见变异。
  • 细胞培养中,STAB2的VTE相关变异与参考STAB2相比表面表达降低。
  • 在独立队列中,携带罕见STAB2变异者与对照相比血管性血友病因子水平更高,前肽水平相当。

临床怎么用

  • 目前描述的VTE变异不足以常规用于临床决策。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Deep vein thrombosis and pulmonary embolism, collectively defined as venous thromboembolism (VTE), are the third leading cause of cardiovascular death in the United States. Common genetic variants conferring increased varying degrees of VTE risk have been identified by genome-wide association studies (GWAS). Rare mutations in the anticoagulant genes PROC, PROS1 and SERPINC1 result in perinatal lethal thrombosis in homozygotes and markedly increased VTE risk in heterozygotes. However, currently described VTE variants account for an insufficient portion of risk to be routinely used for clinical decision making. To identify new rare VTE risk variants, we performed a whole-exome study of 393 individuals with unprovoked VTE and 6114 controls. This study identified 4 genes harboring an excess number of rare damaging variants in patients with VTE: PROS1, STAB2, PROC, and SERPINC1. At STAB2, 7.8% of VTE cases and 2.4% of controls had a qualifying rare variant. In cell culture, VTE-associated variants of STAB2 had a reduced surface expression compared with reference STAB2. Common variants in STAB2 have been previously associated with plasma von Willebrand factor and coagulation factor VIII levels in GWAS, suggesting that haploinsufficiency of stabilin-2 may increase VTE risk through elevated levels of these procoagulants. In an independent cohort, we found higher von Willebrand factor levels and equivalent propeptide levels in individuals with rare STAB2 variants compared with controls. Taken together, this study demonstrates the utility of gene-based collapsing analyses to identify loci harboring an excess of rare variants with functional connections to a complex thrombotic disease.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Desch KC, Ozel AB, Halvorsen M, et al. Whole-exome sequencing identifies rare variants in STAB2 associated with venous thromboembolic disease. Blood. 2020. PMID: 32457982. doi:10.1182/blood.2019004161

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。